Human mp52 arg protein

This invention relates to a human MP52 Arg and a pharmaceutical medical composition inter alia for promoting cartilage and bone morphogenation comprising human MP52 Arg. In particular, the medical composition is useful for treating bone diseases caused by abnormal bone metabolism such as osteoporosis, for treating bone fracture and for the purpose of orthopedic reconstruction, bone transplantation, cosmetic surgery and dental therapeutics. Further, it is useful for treating cartilage disorders.